Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488


Clinical Trial News

Two new migraine prevention drugs show promise in small studies

Two drugs for preventing, rather than stopping attacks once they have started, show promising results in the first studies to test monoclonal antibodies for migraine prevention.

MSU physicists push new Parkinson's treatment toward clinical trials

The most effective way to tackle debilitating diseases is to punch them at the start and keep them from growing.

Volasertib, Boehringer Ingelheim's investigational oncology compound, is granted Orphan Drug Designation for acute myeloid leukemia in the U.S. and EU

Boehringer Ingelheim Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) and European Commission (EC) have granted Orphan Drug Designation to volasertib for acute...

Revolutionary clinical trial aims to advance lung cancer treatment

Cancer Research UK is partnering with pharmaceutical companies AstraZeneca and Pfizer to create a pioneering clinical trial for patients with advanced lung cancer - marking a new era of research...

Chimeric mouse study 'could have prevented human deaths in 1993 drug trial'

Should 'humanized' mice be used routinely in preclinical drug trials? A study finds that adoption of this animal test could have saved human lives in a fatal clinical trial.

Chinese herbal remedy 'just as effective as methotrexate against arthritis'

A Chinese herbal remedy - Triptergium wilfordii Hook F - is just as effective for treating symptoms of rheumatoid arthritis than commonly used drug methotrexate, a study suggests.

Interferon-free therapy for hepatitis C 'cured' 90% of patients

An experimental oral therapy for hepatitis C took only 12 weeks to cure 90% of patients with liver cirrhosis and was found safe for those who could not have interferon.

Indoor rabbits could be deficient in vitamin D

Rabbits that remain indoors may suffer from a lack of vitamin D, researchers report in a new study.

James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook